
BMY News
Bristol-Myers Squibb Company
$63.43
+$1.11(+1.78%)
69
Overall
90
Value
63
Tech
55
Quality
Market Cap
$129.66B
Volume
9.27M
52W Range
$45.27 - $68.64
Target Price
$65.41
BMY news: the latest Bristol-Myers Squibb Company headlines, press releases and market updates, newest first.
Latest BMY News
- Time to Diversify Out of SemiconductorsTheStreet Pro · Nov 3, 2026
- Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Tiziana Life Sciences (TLSA) and Verastem (VSTM)TipRanks Newsroom · Nov 3, 2026
- Cantor Fitzgerald Reaffirms Their Hold Rating on Bristol-Myers Squibb (BMY)TipRanks Auto-Generated Intelligence Newsdesk · Oct 30, 2026
- Exelixis and BMY Extend Access to Key Cancer Drugs in New Long Term StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 28, 2026
- Bristol-Myers Squibb (BMY) Gets a Hold from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Bristol-Myers Squibb (BMY) and Parabilis Medicines, Inc. (PBLS)TipRanks Newsroom · Oct 26, 2026
- Berenberg Bank Reaffirms Their Buy Rating on Bloomsbury Publishing (BMY)TipRanks Auto-Generated Intelligence Newsdesk · Oct 22, 2026
- Analysts Conflicted on These Healthcare Names: Perspective Therapeutics (CATX), Bristol-Myers Squibb (BMY) and Incyte (INCY)TipRanks Newsroom · Oct 17, 2026
- Analysts Conflicted on These Healthcare Names: Perspective Therapeutics (CATX), Bristol-Myers Squibb (BMY) and Incyte (INCY)TipRanks Newsroom · Oct 17, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BMY | $63.43 | +1.8% | 9.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bristol-Myers Squibb Company Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW